Globavir Company
A New Approach to Treating Global Infectious Diseases
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Los Altos, California, United States
Founded Date:
2013-07-01
Last Funding Date:
2018-05-01
Total Funding:
11500000.0
Technology:
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investors Number:
2.0
Industry:
Drug Repurposing